Amneal Pharma to build two new manufacturing facilities in Ahmedabad

Published On 2024-10-10 08:57 GMT   |   Update On 2024-10-10 10:41 GMT

New Delhi: US- based Amneal Pharmaceuticals to build two new manufacturing facilities in Ahmedabad with an investment of up to USD 200 million (nearly Rs 1,680 crore).

"In this latest expansion in India, Amneal will make a total net investment of between USD 150 million and USD 200 million over the next four to five years to build two new greenfield facilities...," the Company said.

Of two greenfield facilities planned, one will be for peptide synthesis and one for advanced sterile fill-finish manufacturing, the company said in a statement.

According to PTI, Amneal Pharmaceuticals co-founders and co-chief executive officers Chirag Patel and Chintu Patel said, "With these new facilities, we are proud to be at the forefront of developing and manufacturing innovative, branded medicines at scale in India, which will supply the local market and the rest of the world."

The company which started operations in India in 2008, currently has 8 manufacturing sites, including 5 in Ahmedabad with additional sites in Dahej, Hyderabad and Vizag, and commercial offices in Mumbai.

It has invested approximately USD 600 million in India over the past 10 years.

These facilities have a collective capacity of producing up to approximately 60 million units of injectables and 8.5 billion tablets annually, the company said.

Read also: Amneal Pharma starts commercial operations in India

Tags:    
Article Source : With inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News